MindImmune

MindImmune Therapeutics

This company develops monoclonal antibody therapeutics to treat neurodegenerative diseases and neuroinflammation for patients with central nervous system disorders.

Muna Therapeutics

This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.

Monument Biosciences

This biotechnology company develops disease-modifying drugs and translational biomarkers to treat Alzheimer's disease and related dementias.

AZ Therapies

This biopharmaceutical company develops therapies for neurodegenerative diseases, including Alzheimer's disease and ischaemic stroke, to treat patients and improve their cognitive health.

BioClec

This biotechnology firm develops therapies targeting brain immune cells to treat patients with Alzheimer's disease.

NeuroTherapia

This clinical-stage company develops oral small-molecule therapies targeting neuroinflammation for patients with Alzheimer's disease and other neurodegenerative disorders.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

Alzinova

This biopharmaceutical company develops immunotherapies and vaccines targeting toxic amyloid-beta oligomers to treat and prevent Alzheimer's disease for patients worldwide.